-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The performance of chemical giants at a glance
Dow recently said that due to the impact of falling local prices, the most important factor being the hydrocarbon business, and the impact of continued adverse global currency exchange rates, the company's first-quarter sales were $10.
7 billion, down 13%
year-on-year.
Over the same period, volumes rose 4 percent, with volume growth in emerging markets driven primarily by Greater China and India, reflecting strong consumer-driven demand
in those regions.
Operating EBITDA for the quarter was $2.
3 billion, down $0.
1 billion year-over-year, and operating EBITDA margin rose from 19 percent to 21 percent, the highest level
in more than a decade.
BASF's sales in the first quarter of 2016 fell by 29 percent year-on-year to €14.
2 billion.
Overall volumes were flat year-on-year, with volumes in the Functional Materials & Solutions, Oil & Gas and Performance Products segments increasing slightly, while volumes in the Agricultural Solutions and Chemicals segments declined
slightly.
EBIT before special items amounted to €1.
9 billion, down €129 million
.
EBITDA was €2.
8 billion, down €78 million year-on-year
.
Net income was €1.
4 billion, up €213 million
.
Evonik's adjusted EBITDA for 2016 was €565 million, down 13 percent from the particularly strong 2015 prioritization period of €650 million
.
The adjusted EBITDA margin was 18.
2 percent
.
Adjusted net income for the first quarter was €254 million, down 21 percent
from €320 million in the same period in 2015.
Overall, Evonik Group sales contracted by 9 percent to EUR 3,106 million
.
Covestro's EBITDA in the first quarter of fiscal 2016 increased by 29.
3 percent year-on-year to €508 million
.
Urethans & Polycarbonates achieved higher volume growth in its core business, resulting in an overall core volume increase of 8.
5 percent
compared to the prior-year quarter.
Net income totalled EUR 182 million, up 58.
3 percent
year-on-year.
Group sales as a whole fell by 5.
9 percent to around EUR 2.
9 billion
in the first three months of 2016 due to lower selling prices and lower raw material prices.